December 10th 2024
The Venclexta-based regimen improved complete response rates in patients with acute myeloid leukemia and myelodysplastic syndromes.
December 9th 2024
December 9th 2024
December 6th 2024
December 5th 2024
December 4th 2024
December 6th 2024
December 5th 2024
December 1st 2024
November 24th 2024
November 30th 2024
November 27th 2024
November 23rd 2024
November 16th 2024